
National Mar 9, 2021
Drugmakers in Japan struggle to keep pace in COVID-19 medicine race
by Osamu Tsukimori
No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.